ALVR logo Allovir Inc : ALVR

ALVR

Stock Data

$4.72

Change up

$0.17 (3.74%)

Asset Type

N/A

Exchange

N/A

Currency

N/A

Country

N/A

Sector

N/A

Industry

N/A

Allovir, Inc., a clinical-stage cell therapy company, is dedicated to the research and development of ready-to-use, multi-virus-specific allogeneic T-cell therapies (TSVs) to prevent and treat devastating virus-associated diseases. The company is headquartered in Cambridge, Massachusetts.

All ALVR Articles

11 Articles

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.